|
Phenotypic Information (metabolism pathway, cancer, disease, phenome) | |
Gene-Gene Network Information: Co-Expression Network, Interacting Genes & KEGG | |
Gene Summary for NME1 |
Basic gene info. | Gene symbol | NME1 |
Gene name | NME/NM23 nucleoside diphosphate kinase 1 | |
Synonyms | AWD|GAAD|NB|NBS|NDKA|NDPK-A|NDPKA|NM23|NM23-H1 | |
Cytomap | UCSC genome browser: 17q21.3 | |
Genomic location | chr17 :49230919-49239450 | |
Type of gene | protein-coding | |
RefGenes | NM_000269.2, NM_198175.1, | |
Ensembl id | ENSG00000239672 | |
Description | NDP kinase Agranzyme A-activated DNasemetastasis inhibition factor nm23non-metastatic cells 1, protein (NM23A) expressed innucleoside diphosphate kinase Atumor metastatic process-associated protein | |
Modification date | 20141207 | |
dbXrefs | MIM : 156490 | |
HGNC : HGNC | ||
Ensembl : ENSG00000239672 | ||
HPRD : 01131 | ||
Vega : OTTHUMG00000137474 | ||
Protein | UniProt: P15531 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_NME1 | |
BioGPS: 4830 | ||
Gene Expression Atlas: ENSG00000239672 | ||
The Human Protein Atlas: ENSG00000239672 | ||
Pathway | NCI Pathway Interaction Database: NME1 | |
KEGG: NME1 | ||
REACTOME: NME1 | ||
ConsensusPathDB | ||
Pathway Commons: NME1 | ||
Metabolism | MetaCyc: NME1 | |
HUMANCyc: NME1 | ||
Regulation | Ensembl's Regulation: ENSG00000239672 | |
miRBase: chr17 :49,230,919-49,239,450 | ||
TargetScan: NM_000269 | ||
cisRED: ENSG00000239672 | ||
Context | iHOP: NME1 | |
cancer metabolism search in PubMed: NME1 | ||
UCL Cancer Institute: NME1 | ||
Assigned class in ccmGDB | A - This gene has a literature evidence and it belongs to cancer gene. | |
References showing role of NME1 in cancer cell metabolism | 1. Matimba A, Li F, Livshits A, Cartwright CS, Scully S, et al. (2014) Thiopurine pharmacogenomics: association of SNPs with clinical response and functional validation of candidate genes. Pharmacogenomics 15: 433-447. go to article |
Top |
Phenotypic Information for NME1(metabolism pathway, cancer, disease, phenome) |
Cancer Description | |
Cancer | CGAP: NME1 |
Familial Cancer Database: NME1 |
* This gene is included in those cancer gene databases. |
Oncogene 1 | Significant driver gene in |
cf) number; DB name 1 Oncogene; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 2 Tumor Suppressor gene; https://bioinfo.uth.edu/TSGene/, 3 Cancer Gene Census; http://www.nature.com/nrc/journal/v4/n3/abs/nrc1299.html, 4 CancerGenes; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 5 Network of Cancer Gene; http://ncg.kcl.ac.uk/index.php, 1Therapeutic Vulnerabilities in Cancer; http://cbio.mskcc.org/cancergenomics/statius/ |
Metabolic Pathway Description | |
KEGG_PURINE_METABOLISM KEGG_PYRIMIDINE_METABOLISM REACTOME_METABOLISM_OF_NUCLEOTIDES |
Others | |
OMIM | 156490; gene. |
Orphanet | |
Disease | KEGG Disease: NME1 |
MedGen: NME1 (Human Medical Genetics with Condition) | |
ClinVar: NME1 | |
Phenotype | MGI: NME1 (International Mouse Phenotyping Consortium) |
PhenomicDB: NME1 |
Mutations for NME1 |
* Under tables are showing count per each tissue to give us broad intuition about tissue specific mutation patterns.You can go to the detailed page for each mutation database's web site. |
Structural Variants in COSMIC: go to COSMIC mutation histogram |
There's no structural variation information in COSMIC data for this gene. |
Related fusion transcripts : go to Chitars2.0 |
* From mRNA Sanger sequences, Chitars2.0 arranged chimeric transcripts. This table shows NME1 related fusion information. |
ID | Head Gene | Tail Gene | Accession | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a |
BF762367 | NME1 | 42 | 125 | 17 | 49239270 | 49239353 | LRP5 | 121 | 388 | 11 | 68183863 | 68191091 | |
BE765003 | NME1 | 12 | 143 | 17 | 49230965 | 49233086 | THRA | 135 | 205 | 17 | 38246322 | 38246392 | |
BC107894 | NME1 | 3 | 594 | 17 | 51153559 | 51162089 | NME2 | 595 | 1195 | 17 | 51165435 | 51171744 | |
BC133029 | NME1 | 1 | 375 | 17 | 51153559 | 51162089 | NME2 | 376 | 875 | 17 | 51165435 | 51171744 | |
BC133031 | NME1 | 1 | 375 | 17 | 51153559 | 51162089 | NME2 | 376 | 875 | 17 | 51165435 | 51171744 |
Other DBs for Structural Variants |
Top |
Copy Number Variations in COSMIC: go to COSMIC mutation CNV/Expr |
Mutation type/ Tissue ID | brca | cns | cerv | endome | haematopo | kidn | Lintest | liver | lung | ns | ovary | pancre | prost | skin | stoma | thyro | urina | |||
Total # sample | 1 |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   | |||
GAIN (# sample) | 1 |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   | |||
LOSS (# sample) |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
cf) Tissue ID; Tissue type (1; Breast, 2; Central_nervous_system, 3; Cervix, 4; Endometrium, 5; Haematopoietic_and_lymphoid_tissue, 6; Kidney, 7; Large_intestine, 8; Liver, 9; Lung, 10; NS, 11; Ovary, 12; Pancreas, 13; Prostate, 14; Skin, 15; Stomach, 16; Thyroid, 17; Urinary_tract) |
Top |
SNV Counts per Each Loci in COSMIC data: go to COSMIC point mutation |
|
Top |
Somatic Mutation Counts per Tissue in COSMIC data |
Stat. for Non-Synonymous SNVs (# total SNVs=7) | (# total SNVs=5) |
(# total SNVs=0) | (# total SNVs=0) |
Top |
Top 10 SNVs Having the Most Samples in COSMIC data |
* When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site,primary_histology,mutation(aa),pubmedID. |
GRCh37 position | Mutation(aa) | Unique sampleID count |
chr17:49233063-49233063 | p.V41V | 1 |
chr17:49239159-49239159 | p.E163K | 1 |
chr17:49233106-49233106 | p.K56E | 1 |
chr17:49239204-49239204 | p.*178R | 1 |
chr17:49237347-49237347 | p.E70K | 1 |
chr17:49237348-49237348 | p.E70A | 1 |
chr17:49237379-49237379 | p.L80L | 1 |
chr17:49237387-49237387 | p.R83H | 1 |
chr17:49237425-49237425 | p.G96W | 1 |
chr17:49238549-49238549 | p.T111M | 1 |
Top |
SNV Counts per Each Loci in TCGA data |
|
Point Mutation/ Tissue ID | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |
# sample |   |   |   | 1 |   |   |   |   |   |   |   |   | 1 |   |   |   |   |   |   | 1 |
# mutation |   |   |   | 1 |   |   |   |   |   |   |   |   | 1 |   |   |   |   |   |   | 1 |
nonsynonymous SNV |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
synonymous SNV |   |   |   | 1 |   |   |   |   |   |   |   |   | 1 |   |   |   |   |   |   | 1 |
cf) Tissue ID; Tissue type (1; BLCA[Bladder Urothelial Carcinoma], 2; BRCA[Breast invasive carcinoma], 3; CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], 4; COAD[Colon adenocarcinoma], 5; GBM[Glioblastoma multiforme], 6; Glioma Low Grade, 7; HNSC[Head and Neck squamous cell carcinoma], 8; KICH[Kidney Chromophobe], 9; KIRC[Kidney renal clear cell carcinoma], 10; KIRP[Kidney renal papillary cell carcinoma], 11; LAML[Acute Myeloid Leukemia], 12; LUAD[Lung adenocarcinoma], 13; LUSC[Lung squamous cell carcinoma], 14; OV[Ovarian serous cystadenocarcinoma ], 15; PAAD[Pancreatic adenocarcinoma], 16; PRAD[Prostate adenocarcinoma], 17; SKCM[Skin Cutaneous Melanoma], 18:STAD[Stomach adenocarcinoma], 19:THCA[Thyroid carcinoma], 20:UCEC[Uterine Corpus Endometrial Carcinoma]) |
Top |
Top 10 SNVs Having the Most Samples in TCGA data |
* We represented just top 10 SNVs. When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site, primary_histology, mutation(aa), pubmedID. |
Genomic Position | Mutation(aa) | Unique sampleID count |
chr17:49231764 | p.V10V | 1 |
chr17:49239125 | p.A126A,NME1 | 1 |
chr17:49239140 | p.G131G,NME1 | 1 |
Other DBs for Point Mutations |
Copy Number for NME1 in TCGA |
* Copy number data were extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered on Jan-05-2015. Function ProcessCNAData in TCGA-Assembler package was used to obtain gene-level copy number value which is calculated as the average copy number of the genomic region of a gene. |
cf) Tissue ID[Tissue type]: BLCA[Bladder Urothelial Carcinoma], BRCA[Breast invasive carcinoma], CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], COAD[Colon adenocarcinoma], GBM[Glioblastoma multiforme], Glioma Low Grade, HNSC[Head and Neck squamous cell carcinoma], KICH[Kidney Chromophobe], KIRC[Kidney renal clear cell carcinoma], KIRP[Kidney renal papillary cell carcinoma], LAML[Acute Myeloid Leukemia], LUAD[Lung adenocarcinoma], LUSC[Lung squamous cell carcinoma], OV[Ovarian serous cystadenocarcinoma ], PAAD[Pancreatic adenocarcinoma], PRAD[Prostate adenocarcinoma], SKCM[Skin Cutaneous Melanoma], STAD[Stomach adenocarcinoma], THCA[Thyroid carcinoma], UCEC[Uterine Corpus Endometrial Carcinoma] |
Top |
Gene Expression for NME1 |
Gene Expression in Cancer Cell-lines (CCLE) |
* CCLE gene expression data were extracted from CCLE_Expression_Entrez_2012-10-18.res: Gene-centric RMA-normalized mRNA expression data. |
Differential Gene Expression in Primary Tumors (TCGA) |
* Normalized gene expression data of RNASeqV2 was extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered at Jan-05-2015. Only eight cancer types have enough normal control samples for differential expression analysis. (t test, adjusted p<0.05 (using Benjamini-Hochberg FDR)) |
Top |
CNV vs Gene Expression Plot |
* This plots show the correlation between CNV and gene expression. |
Top |
Gene-Gene Network Information |
Co-Expressed gene's network Plot |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
AURKAIP1,C19orf70,CLPP,CUEDC2,EEF1D,MRPL27,MRPL54, MYL6,NDUFA11,NDUFA13,NDUFS7,NME1,NME1-NME2,NME2, NME2P1,NUDC,PIN1,SNF8,TIMM13,UQCR11,VPS28 | ASNA1,EMC10,DNPH1,COPE,EXOSC4,FIBP,GIPC1, HSPBP1,MPG,MPND,MRPS12,NHP2,NME1,NME1-NME2, NUBP2,PHB,PPP4C,PTRH1,RUVBL2,TIMM13,TSTA3 | ||||
ALG3,ATAD3B,BCL2L12,C16orf59,AUNIP,CCDC37,MRPL28, MRTO4,NDUFS8,TONSL,NME1-NME2,NOC2L,NUDC,PKMYT1, POLR3K,PSMB2,RECQL4,SLC4A9,SPO11,SRM,TUBG1 | CLPB,EEF2KMT,FJX1,FXN,G6PC3,GTPBP4,HAUS7, HM13,HSPBP1,LYAR,MLKL,MMP3,NME1-NME2,NOP2, PA2G4,RIPK2,RUVBL1,SDF2L1,SRM,USP14,WDR4 |
Co-Expressed gene's Protein-protein interaction Network Plot |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
Top |
Interacting Genes (from Pathway Commons) |
Top |
Pharmacological Information for NME1 |
Cross-referenced pharmacological DB IDs from Uniprot |
DB Category | DB Name | DB's ID and Url link |
Chemistry | ChEMBL | CHEMBL2159; -. |
Organism-specific databases | PharmGKB | PA249; -. |
Organism-specific databases | CTD | 4830; -. |
Drug-Gene Interaction Network |
* Gene Centered Interaction Network. |
* Drug Centered Interaction Network. |
DrugBank ID | Target Name | Drug Groups | Generic Name | Drug Centered Network | Drug Structure |
DB02181 | NME/NM23 nucleoside diphosphate kinase 1 | experimental | 2'-Deoxyguanosine-5'-Triphosphate | ||
DB02212 | NME/NM23 nucleoside diphosphate kinase 1 | experimental | Pyrophosphate 2- | ||
DB02345 | NME/NM23 nucleoside diphosphate kinase 1 | experimental | Selenocysteine | ||
DB02569 | NME/NM23 nucleoside diphosphate kinase 1 | experimental | 2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Diphosphate | ||
DB02607 | NME/NM23 nucleoside diphosphate kinase 1 | experimental | Adenosine Phosphonoacetic Acid | ||
DB02887 | NME/NM23 nucleoside diphosphate kinase 1 | experimental | 2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Triphosphate | ||
DB03103 | NME/NM23 nucleoside diphosphate kinase 1 | experimental | Thymidine-5'- Diphosphate | ||
DB03431 | NME/NM23 nucleoside diphosphate kinase 1 | experimental | Adenosine-5'-Diphosphate | ||
DB03491 | NME/NM23 nucleoside diphosphate kinase 1 | experimental | 2'-Deoxyguanosine-5'-Diphosphate | ||
DB04068 | NME/NM23 nucleoside diphosphate kinase 1 | experimental | Fudp | ||
DB04315 | NME/NM23 nucleoside diphosphate kinase 1 | experimental | Guanosine-5'-Diphosphate | ||
DB04366 | NME/NM23 nucleoside diphosphate kinase 1 | experimental | 3'-Deoxy 3'-Amino Adenosine-5'-Diphosphate | ||
DB04542 | NME/NM23 nucleoside diphosphate kinase 1 | experimental | 3'-Azido-3'-Deoxythymidine-5'-Diphosphate | ||
DB00709 | NME/NM23 nucleoside diphosphate kinase 1 | approved; investigational | Lamivudine | ||
DB00171 | NME/NM23 nucleoside diphosphate kinase 1 | approved; nutraceutical | Adenosine triphosphate | ||
DB00495 | NME/NM23 nucleoside diphosphate kinase 1 | approved | Zidovudine | ||
DB00544 | NME/NM23 nucleoside diphosphate kinase 1 | approved | Fluorouracil | ||
DB00122 | NME/NM23 nucleoside diphosphate kinase 1 | approved; nutraceutical | Choline | ||
DB00130 | NME/NM23 nucleoside diphosphate kinase 1 | approved; nutraceutical; investigational | L-Glutamine |
Top |
Cross referenced IDs for NME1 |
* We obtained these cross-references from Uniprot database. It covers 150 different DBs, 18 categories. http://www.uniprot.org/help/cross_references_section |
Copyright © 2016-Present - The Univsersity of Texas Health Science Center at Houston @ |